purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncolytic Virus Therapy
1.2 Key Market Segments
1.2.1 Oncolytic Virus Therapy Segment by Type
1.2.2 Oncolytic Virus Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncolytic Virus Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oncolytic Virus Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncolytic Virus Therapy Market Competitive Landscape
3.1 Global Oncolytic Virus Therapy Sales by Manufacturers (2019-2025)
3.2 Global Oncolytic Virus Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncolytic Virus Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Oncolytic Virus Therapy Sales Sites, Area Served, Product Type
3.6 Oncolytic Virus Therapy Market Competitive Situation and Trends
3.6.1 Oncolytic Virus Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncolytic Virus Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncolytic Virus Therapy Industry Chain Analysis
4.1 Oncolytic Virus Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncolytic Virus Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncolytic Virus Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Therapy Sales Market Share by Type (2019-2025)
6.3 Global Oncolytic Virus Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Oncolytic Virus Therapy Price by Type (2019-2025)
7 Oncolytic Virus Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Therapy Market Sales by Application (2019-2025)
7.3 Global Oncolytic Virus Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Oncolytic Virus Therapy Sales Growth Rate by Application (2019-2025)
8 Oncolytic Virus Therapy Market Consumption by Region
8.1 Global Oncolytic Virus Therapy Sales by Region
8.1.1 Global Oncolytic Virus Therapy Sales by Region
8.1.2 Global Oncolytic Virus Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Oncolytic Virus Therapy Market Production by Region
9.1 Global Production of Oncolytic Virus Therapy by Region (2019-2025)
9.2 Global Oncolytic Virus Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Oncolytic Virus Therapy Production
9.4.1 North America Oncolytic Virus Therapy Production Growth Rate (2019-2025)
9.4.2 North America Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Oncolytic Virus Therapy Production
9.5.1 Europe Oncolytic Virus Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Oncolytic Virus Therapy Production (2019-2025)
9.6.1 Japan Oncolytic Virus Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Oncolytic Virus Therapy Production (2019-2025)
9.7.1 China Oncolytic Virus Therapy Production Growth Rate (2019-2025)
9.7.2 China Oncolytic Virus Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Amgen
10.1.1 Amgen Oncolytic Virus Therapy Basic Information
10.1.2 Amgen Oncolytic Virus Therapy Product Overview
10.1.3 Amgen Oncolytic Virus Therapy Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen Oncolytic Virus Therapy SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 Oncolytics Biotech
10.2.1 Oncolytics Biotech Oncolytic Virus Therapy Basic Information
10.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Overview
10.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product Market Performance
10.2.4 Oncolytics Biotech Business Overview
10.2.5 Oncolytics Biotech Oncolytic Virus Therapy SWOT Analysis
10.2.6 Oncolytics Biotech Recent Developments
10.3 Viralytics
10.3.1 Viralytics Oncolytic Virus Therapy Basic Information
10.3.2 Viralytics Oncolytic Virus Therapy Product Overview
10.3.3 Viralytics Oncolytic Virus Therapy Product Market Performance
10.3.4 Viralytics Oncolytic Virus Therapy SWOT Analysis
10.3.5 Viralytics Business Overview
10.3.6 Viralytics Recent Developments
10.4 Transgene SA
10.4.1 Transgene SA Oncolytic Virus Therapy Basic Information
10.4.2 Transgene SA Oncolytic Virus Therapy Product Overview
10.4.3 Transgene SA Oncolytic Virus Therapy Product Market Performance
10.4.4 Transgene SA Business Overview
10.4.5 Transgene SA Recent Developments
10.5 Oncolys BioPharma
10.5.1 Oncolys BioPharma Oncolytic Virus Therapy Basic Information
10.5.2 Oncolys BioPharma Oncolytic Virus Therapy Product Overview
10.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product Market Performance
10.5.4 Oncolys BioPharma Business Overview
10.5.5 Oncolys BioPharma Recent Developments
10.6 Targovax
10.6.1 Targovax Oncolytic Virus Therapy Basic Information
10.6.2 Targovax Oncolytic Virus Therapy Product Overview
10.6.3 Targovax Oncolytic Virus Therapy Product Market Performance
10.6.4 Targovax Business Overview
10.6.5 Targovax Recent Developments
10.7 PsiOxus Therapeutics
10.7.1 PsiOxus Therapeutics Oncolytic Virus Therapy Basic Information
10.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Overview
10.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product Market Performance
10.7.4 PsiOxus Therapeutics Business Overview
10.7.5 PsiOxus Therapeutics Recent Developments
10.8 SillaJen Biotherapeutics
10.8.1 SillaJen Biotherapeutics Oncolytic Virus Therapy Basic Information
10.8.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Overview
10.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Market Performance
10.8.4 SillaJen Biotherapeutics Business Overview
10.8.5 SillaJen Biotherapeutics Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Oncolytic Virus Therapy Basic Information
10.9.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Overview
10.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Lokon Pharma
10.10.1 Lokon Pharma Oncolytic Virus Therapy Basic Information
10.10.2 Lokon Pharma Oncolytic Virus Therapy Product Overview
10.10.3 Lokon Pharma Oncolytic Virus Therapy Product Market Performance
10.10.4 Lokon Pharma Business Overview
10.10.5 Lokon Pharma Recent Developments
10.11 Genelux Corporation
10.11.1 Genelux Corporation Oncolytic Virus Therapy Basic Information
10.11.2 Genelux Corporation Oncolytic Virus Therapy Product Overview
10.11.3 Genelux Corporation Oncolytic Virus Therapy Product Market Performance
10.11.4 Genelux Corporation Business Overview
10.11.5 Genelux Corporation Recent Developments
10.12 Vyriad
10.12.1 Vyriad Oncolytic Virus Therapy Basic Information
10.12.2 Vyriad Oncolytic Virus Therapy Product Overview
10.12.3 Vyriad Oncolytic Virus Therapy Product Market Performance
10.12.4 Vyriad Business Overview
10.12.5 Vyriad Recent Developments
10.13 TILT Biotherapeutics
10.13.1 TILT Biotherapeutics Oncolytic Virus Therapy Basic Information
10.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Overview
10.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product Market Performance
10.13.4 TILT Biotherapeutics Business Overview
10.13.5 TILT Biotherapeutics Recent Developments
10.14 Cold Genesys
10.14.1 Cold Genesys Oncolytic Virus Therapy Basic Information
10.14.2 Cold Genesys Oncolytic Virus Therapy Product Overview
10.14.3 Cold Genesys Oncolytic Virus Therapy Product Market Performance
10.14.4 Cold Genesys Business Overview
10.14.5 Cold Genesys Recent Developments
11 Oncolytic Virus Therapy Market Forecast by Region
11.1 Global Oncolytic Virus Therapy Market Size Forecast
11.2 Global Oncolytic Virus Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Therapy Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Oncolytic Virus Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oncolytic Virus Therapy by Type (2025-2032)
12.1.2 Global Oncolytic Virus Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oncolytic Virus Therapy by Type (2025-2032)
12.2 Global Oncolytic Virus Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Oncolytic Virus Therapy Sales (K Units) Forecast by Application
12.2.2 Global Oncolytic Virus Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings